TriSalus Life Sciences Inc
Research TriSalus Life Sciences Inc (TLSI) on Bullrun: market cap USD 291.11M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTLSI
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 291.11M
- Financial periodFY2025
- RevenueUSD 45.15M
- Revenue growth53.4%
- Net income-USD 39.23M
- Free cash flow-USD 18.93M
- Gross margin84.6%
Valuation Snapshot
latest market cap is USD 291.11M.
About TriSalus Life Sciences Inc
TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD) infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases;
Frequently asked questions
What is TriSalus Life Sciences Inc's market cap?
TriSalus Life Sciences Inc's market capitalization is USD 291.11M.
What does TriSalus Life Sciences Inc do?
TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States.